The Group focuses on studying the prevalence and etiopathogenetic mechanisms of amyloidosis in order to improve the efficiency of diagnosis and treatment of the disease.
Major focus and ongoing projects:
- Developing algorithms for the diagnosis and treatment of patients with various forms of cardiac amyloidosis
- Creating the biomaterial and patient data bank
- Analyzing the morphological features of changes in the myocardial stroma in various forms of amyloid disease
- Studying the features and patterns of fibrillogenesis of amyloidogenic proteins and assessing the influencing factors